Gayle Mills

Gayle Mills

Corporate Officer/Principal chez BERGENBIO ASA

69 ans
Health Technology
Consumer Services

Profil

Gayle M.
Mills
is currently the Chief Business Officer at BerGenBio ASA since 2021.
Prior to this, she was the Chief Business Officer at Alligator Bioscience AB from 2020 to 2021.
She has also held various business development positions at Syntex Corp., Abgenix, Inc., Sandoz, Inc., ROXRO Pharma, Inc., Symphogen A, Syntex (USA), Inc., and Roche Bioscience.
Mills completed her undergraduate degree at the University of Notre Dame and earned an MBA from Santa Clara University.

Postes actifs de Gayle Mills

SociétésPosteDébut
BERGENBIO ASA Corporate Officer/Principal 01/01/2021
Tous les postes actifs de Gayle Mills

Anciens postes connus de Gayle Mills

SociétésPosteFin
ALLIGATOR BIOSCIENCE AB Corporate Officer/Principal 29/10/2021
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Gayle Mills

Formation de Gayle Mills

University of Notre Dame Undergraduate Degree
Santa Clara University Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Gayle Mills

Relations

34

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
ALLIGATOR BIOSCIENCE AB

Health Technology

BERGENBIO ASA

Health Technology

Entreprise privées8

Health Technology

Syntex Corp.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Gayle Mills